1,784
Views
4
CrossRef citations to date
0
Altmetric
Anticancer Original Research Paper

Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer

ORCID Icon, , , , , , & show all
Pages 492-498 | Received 03 Nov 2020, Accepted 16 Mar 2021, Published online: 05 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)